These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 16206589)
1. [Effect of infusion therapy on central hemodynamics and the outcome of treatment in patients with subarachnoidal hemorrhages]. Shatalov VI; Shchegolev AV Anesteziol Reanimatol; 2005; (4):55-8. PubMed ID: 16206589 [TBL] [Abstract][Full Text] [Related]
4. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage. Kerz T; Boor S; Beyer C; Welschehold S; Schuessler A; Oertel J Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Hänggi D; Beseoglu K; Turowski B; Steiger HJ Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777 [TBL] [Abstract][Full Text] [Related]
6. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [TBL] [Abstract][Full Text] [Related]
7. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation. Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152 [TBL] [Abstract][Full Text] [Related]
8. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461 [TBL] [Abstract][Full Text] [Related]
9. Role of transcranial Doppler in optimizing treatment of cerebral vasospasm in subarachnoid hemorrhage. Darwish RS; Ahn E; Amiridze NS J Intensive Care Med; 2008; 23(4):263-7. PubMed ID: 18480082 [TBL] [Abstract][Full Text] [Related]
10. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. Stuart RM; Helbok R; Kurtz P; Schmidt M; Fernandez L; Lee K; Badjatia N; Mayer SA; Lavine S; Meyers P; Connolly ES; Claassen J Neurosurgery; 2011 Feb; 68(2):337-45; discussion 345. PubMed ID: 21135735 [TBL] [Abstract][Full Text] [Related]
11. Intraarterial infusion of papaverine and change of cerebral hemodynamics in symptomatic cerebral vasospasm. Minami H; Kuwamura K; Tamaki N Kobe J Med Sci; 2001 Aug; 47(4):169-79. PubMed ID: 11733656 [TBL] [Abstract][Full Text] [Related]
12. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series. Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991 [TBL] [Abstract][Full Text] [Related]
13. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage. Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460 [TBL] [Abstract][Full Text] [Related]
14. [Systemic treatments of the vasospasm]. Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488 [TBL] [Abstract][Full Text] [Related]
15. Evaluation function of transcranial two-dimensional and color Doppler ultrasonography (TCCS) for patients with different degrees of cerebral vasospasm before and after the nimodipine treatment. Wang JL; Li XN; Zhang YH; Li X; Yang YL Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2757-2763. PubMed ID: 28678308 [TBL] [Abstract][Full Text] [Related]
16. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. Bilotta F; Spinelli A; Giovannini F; Doronzio A; Delfini R; Rosa G J Neurosurg Anesthesiol; 2007 Jul; 19(3):156-60. PubMed ID: 17592345 [TBL] [Abstract][Full Text] [Related]
17. Detecting and treating microvascular ischemia after subarachnoid hemorrhage. Sakowitz OW; Unterberg AW Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784 [TBL] [Abstract][Full Text] [Related]
18. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244 [TBL] [Abstract][Full Text] [Related]
19. Intracisternal versus intracarotid infusion of L-arginine in experimental cerebral vasospasm. Ozüm U; Aslan A; Karadağ O; Gürelik M; Taş A; Zafer Kars H J Clin Neurosci; 2007 Jun; 14(6):556-62. PubMed ID: 17430779 [TBL] [Abstract][Full Text] [Related]